Bausch Health Companies BHC
NYSE BHC
$6.86 -0.03 (-0.51%)
At close: Aug 20, 2026 · 3:02 PM UTC

Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012)

Bausch Health Companies (BHC) posted Amortizatization of Intangibles of $3.2 million for Q1 2012, up 63.51% sequentially from $2.0 million in Q4 2011, and up 22.98% YoY from $2.6 million in Q2 2011.

Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012) Analysis & Trends

Bausch Health Companies has reported Amortizatization of Intangibles for 4 years, with the latest figure at $3.2 million in Q1 2012.

  • Quarterly Amortizatization of Intangibles rose 22.98% year-over-year to $3.2 million in Q1 2012, while the trailing twelve-month figure through Mar 2012 was $9.1 million (down 17.37% YoY) and the FY2011 annual result came in at $8.5 million, down 23.98% from the prior year.
  • Amortizatization of Intangibles rose to $3.2 million in Q1 2012 per BHC's latest filing, from $2.0 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $3.2 million in Q1 2012 and troughed at $564000.0 in Q2 2009.
  • A 4-year average of $2.4 million and a median of $2.7 million in 2009 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2010 and 2011: Amortizatization of Intangibles soared 403.01% in 2010, then slumped 31.44% in 2011.
  • Over 4 years, Amortizatization of Intangibles stood at $2.7 million in 2009, then gained by 2.88% to $2.8 million in 2010, then dropped by 29.51% to $2.0 million in 2011, then jumped by 63.51% to $3.2 million in 2012.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $3.2 million, $2.0 million, and $1.9 million for Q1 2012, Q4 2011, and Q3 2011 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn -
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn 900,000.00
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Bausch Health Companies 2.57 Bn 734.50 Mn 2.10 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2012 3.25 Mn
Mar 31, 2012 3.25 Mn
Dec 31, 2011 1.99 Mn
Dec 31, 2011 1.99 Mn
Sep 30, 2011 1.92 Mn
Sep 30, 2011 1.92 Mn
Jun 30, 2011 1.95 Mn
Jun 30, 2011 1.95 Mn
Mar 31, 2011 2.64 Mn
Mar 31, 2011 2.64 Mn
Dec 31, 2010 2.82 Mn
Dec 31, 2010 2.82 Mn
Sep 30, 2010 2.71 Mn
Sep 30, 2010 2.71 Mn
Jun 30, 2010 2.84 Mn
Jun 30, 2010 2.84 Mn
Mar 31, 2010 2.80 Mn
Mar 31, 2010 2.80 Mn
Dec 31, 2009 2.74 Mn
Dec 31, 2009 2.74 Mn